Search results

  1. adambeyoncelowe

    Millions of black people affected by racial bias in health-care algorithms

    “Indifference to social reality is, perhaps, more dangerous than outright bigotry.” This, I think, is the crux of it. Sounds familiar in more ways than one, actually...
  2. adambeyoncelowe

    Millions of black people affected by racial bias in health-care algorithms

    Looks like it's 84% fixable too: https://www.google.com/amp/s/amp.theguardian.com/society/2019/oct/25/healthcare-algorithm-racial-biases-optum
  3. adambeyoncelowe

    Millions of black people affected by racial bias in health-care algorithms

    Looks like it was to do with cost: https://www.google.com/amp/s/www.wsj.com/amp/articles/researchers-find-racial-bias-in-hospital-algorithm-11571941096
  4. adambeyoncelowe

    Your experience of ME services - #MEAction UK survey report concludes services 'not fit for purpose'

    Also, @Michiel Tack, the survey doesn't specifically mention GET but if you read the questions, it looks like it was trying to ascertain what patients were actually given rather than what they were told they were given. I.e., some clinics say 'pacing' or 'activity management' but mean GET, and...
  5. adambeyoncelowe

    ME/CFS services in the United Kingdom

    I think the issue here is that many non-ME-specific services (e.g., pain clinics or rheumatology clinics which only sometimes deal with ME cases) don't feel confident in diagnosing patients. But in my experience, dedicated services typically feel they can recognise 'well defined' cases using...
  6. adambeyoncelowe

    The DePaul Symptom Questionnaire-2: a validation study, 2019, Sunnquist et al

    It's supposed to be used to assess whether one meets criteria for ME (mostly based on the CCC and possibly the ICC with some tweaks). Those using it would be researchers and possibly clinicians. The 'eight-factor domain' roughly corresponds to the symptom requirements for the Canadian Consensus...
  7. adambeyoncelowe

    Cochrane Review: 'Exercise therapy for chronic fatigue syndrome', Larun et al. - New version October 2019 and new date December 2024

    Just to be clear, I don't know what their (Cochrane's) protocol says. But they probably do have a rule about which data point counts as long-term follow-up. That's why I was asking.
  8. adambeyoncelowe

    ME/CFS services in the United Kingdom

    Many do. In fact, I think therapists do the diagnosing in many cases.
  9. adambeyoncelowe

    Cochrane Review: 'Exercise therapy for chronic fatigue syndrome', Larun et al. - New version October 2019 and new date December 2024

    The end points mentioned only go up to about 70-weeks. Does that mean someone forgot to include the 134-week data for PACE? That probably needs correcting if the protocol says to use the furthest end point.
  10. adambeyoncelowe

    ME/CFS services in the United Kingdom

    Often GPs don't know. The clinics aren't always well advertised.
  11. adambeyoncelowe

    The Norwegian ME Association's report on severe ME

    Thanks. It will be useful!
  12. adambeyoncelowe

    Scientific Advances in and Clinical Approaches to Small-Fiber Polyneuropathy (2019) Oaklander et al

    Probably not yet. NICE isn't very interested in theories and this is still at that hypothetical stage. NICE wouldn't do replication either. If this becomes more established, then it could be considered either as an exclusionary diagnosis or as a screening test, depending on whether SFPN is...
  13. adambeyoncelowe

    Dr Nacul speaking tomorrow (Saturday), livestreamed

    You must bear in mind that he can't say anything about the NICE process or appear to have rigid views about the evidence that might be considered biased. Luis can't afford to be accused of having prejudged the evidence, in case that weakens his position on the committee or results in him being...
  14. adambeyoncelowe

    NICE Guideline review: Call for evidence on myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome, deadline 16th Oct 2019

    Thanks. Hypothesis is probably less of interest to NICE than clinical trials but I'll certainly look at everything.
  15. adambeyoncelowe

    Do Alzheimer's and Lewy body disease have discrete pathological signatures of gait?

    Thought this was relevant since @Jonathan Edwards has mentioned gait as a possible diagnostic tool in ME. Link: https://www.alzheimersanddementia.com/article/S1552-5260(19)35120-9/fulltext
  16. adambeyoncelowe

    NICE Guideline review: Call for evidence on myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome, deadline 16th Oct 2019

    Could I suggest that people be allowed to send their comments to you privately? Not everyone wants to post these in a public fashion.
Back
Top Bottom